*Treatment of locally advanced or metastatic non-small cell lung cancer with activating epidermal growth factor receptor (EGFR) mutations, in patients who have not previously been treated with EGFR tyrosine kinase inhibitor:* Adult: 40 mg once daily; increased if tolerated to up to 50 mg once daily,...
| Brand Name | Manufacturer / Company | Available Pack Sizes & Price | Action |
|---|---|---|---|
| AFANIX | 🏢 HIMMEL |
Tab 40 mg 3x10:
Rs.47580.00
|
View Details → |